| BioID | bio29767 |
| Name | BUSPIRONE HYDROCHLORIDE |
| ChEMBL ID | CHEMBL1200399 |
| Molecular Formula | C21H32ClN5O2 |
| Molecular Weight | 421.97 |
| Molecular Weight (Monoisotopic) | 385.2478 |
| Type | Small molecule |
| Max Phase | Phase 4 |
| Target ID | Tar9 |
| Target Name | Neurotensin receptor type 1 (NTSR1) |
| Synonyms | APD-405|APD405|BUSPAR|BUSPIRONE HCL|BUSPIRONE HYDROCHLORIDE|MJ 9022-1|MJ-9022-1|NSC-751138|NSC-759571 |
| Smiles | Cl.O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1 |
| Inchi | InChI=1S/C21H31N5O2.ClH/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20;/h5,8-9H,1-4,6-7,10-17H2;1H |
| Inchi Key | RICLFGYGYQXUFH-UHFFFAOYSA-N |
| Molecular Species | NEUTRAL |
| Targets | 33.0 |
| Bioactivities | 50.0 |
| Np Likeness Score | -1.1 |
| Records Key | ['Buspirone hydrochloride', 'NCGC00093692-01', '1 (buspirone)', 'SID50105965', 'SID11533010', 'BUSPIRONE HYDROCHLORIDE', 'buspirone HCl', 'BUSPIRONE HYDROCHLORIDE', 'BUSPIRONE HYDROCHLORIDE', 'Buspirone hydrochloride', 'BUSPIRONE HYDROCHLORIDE', 'Buspirone HCl', 'Buspirone hydrochloride', 'BUSPIRONE HYDROCHLORIDE', 'BUSPIRONE HYDROCHLORIDE', 'SAM002264597', 'BUSPIRONE HYDROCHLORIDE', 'BUSPIRONE HYDROCHLORIDE', 'SID56422091', 'BUSPIRONE HYDROCHLORIDE'] |
| Records Name | ['8-[4-(4-Pyrimidin-2-yl-piperazin-1-yl)-butyl]-8-aza-spiro[4.5]decane-7,9-dione hydrochloride(Buspirone)', 'Buspirone hydrochloride', '8-[4-(4-Pyrimidin-2-yl-piperazin-1-yl)-butyl]-8-aza-spiro[4.5]decane-7,9-dione: hydrochloride', 'SID50105965', 'SID11533010', 'BUSPIRONE HYDROCHLORIDE', 'buspirone Hydrochloride', 'BUSPIRONE HYDROCHLORIDE', 'BUSPIRONE HYDROCHLORIDE', 'Buspirone hydrochloride', 'BUSPIRONE HYDROCHLORIDE', 'Buspirone Hydrochloride', 'Buspirone hydrochloride', 'BUSPIRONE HYDROCHLORIDE', 'BUSPIRONE HYDROCHLORIDE', 'C0164425', 'BUSPIRONE HYDROCHLORIDE', 'BUSPIRONE HYDROCHLORIDE', 'SID56422091', 'BUSPIRONE HYDROCHLORIDE'] |
| Withdrawn Flag | False |
| Orphan | 0 |